College of Dentistry – 2nd Annual “Decoding MicroRNA Mysteries in Health and Disease” Symposium
Date / Time
September 23, 2021 - September 24, 2021
8:30 am - 5:00 pm
Categories
About this event
The “MicroRNA Symposium” is an international conference that brings together microRNA and other noncoding RNA biologists across the world to share the exciting advances in the field. The current understanding of noncoding RNAs across a spectrum of cellular processes and their use in disease diagnostics & therapeutics is rapidly evolving. Scientists from academia will present results of their ongoing basic and translational research and the challenges in the field of “microRNAs in health and disease” with a focus on cancers, virology, cell metabolism, regeneration and immunology. In addition, this integrated platform aims to foster cross-discipline collaborations, and provide presentation opportunities to graduate students, post-docs and junior investigators.
On behalf of the organizing committee (Dr. Lyndon Cooper and Dr. Afsar Naqvi), we cordially invite noncoding RNA researchers and enthusiasts to participate in this year’s online symposium on September 23-24, 2021.
To Register for this event Signup at –> RSVP
Schedule:
Thursday September 23rd, 2021 (8.45 AM – 4.00 PM Central Time)
Welcome Remarks
8.45 AM – 9.00 AM Afsar Naqvi, University of Illinois at Chicago, USA
Lyndon Cooper, University of Illinois at Chicago, USA
Session 1
9.00 AM – 10.00 AM Frank Slack, Harvard Medical School Keynote Speaker
“Toward personalized microRNA therapeutics”
10.00 AM – 11.00 AM Roopa Biswas, Uniformed Services University of the Health Sciences, USA
“MicroRNA-155: A tale of two diseases”
11.00 AM – 11.45 PM Andrea Kasinski, Purdue University, USA
“Overcoming the bottleneck in delivery of microRNAs via direct ligand conjugation”
11.45 AM – 12.15 PM Lyndon Cooper, University of Illinois at Chicago, USA
“Macrophage exosome-mediated control of bone regeneration”
12.15 PM – 12.45 PM Break
Session 2
12.45 PM – 1.45 PM Richard Carthew, Northwestern University, USA
“MicroRNA interactions with metabolism: A two-way street”
1.45 PM – 2.30 PM Larissa Nonn, University of Illinois at Chicago, USA
“MicroRNAs and prostate cancer: Biomarkers and mediators of disease”
2.30 PM – 3.15 PM Tom Diekwisch, Texas A&M University, USA
“MicroRNAs in Periodontal Homeostasis and Disease”
Short Talks
3.15 PM – 3.30 PM Jaeil Han, UT Southwestern Medical Center, USA
“A ubiquitin ligase mediates target-directed microRNA decay independently of tailing and trimming”
3.30 PM – 3.45 PM Melanie Winkle, M.D. Anderson Cancer Center, Texas State University, USA
“Anti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response”
3.45 PM – 4.00 PM Discussion and Session Closing
Friday, September 24th, 2021 (8.45 AM– 4.00 PM)
Session 1
9.00 AM – 10.00 AM Dirk Dittmer, University of North Carolina at Chapel Hill, USA
“Exosomes carry oncogenic miRNAs in viral cancers”
10.00 AM – 10.45 AM Meaghan Hancock, Oregon Health & Science University, USA
“HCMV miRNA targets reveal signaling pathways important for latency and reactivation in CD34+ hematopoietic progenitor cells”
10.45 AM – 11.30 AM Kannanganattu Prasanth, University of Illinois at Urbana-Champaign, USA
“Role of ncRNAs in cell cycle progression and cancer”
11.30 AM – 12.15 AM Sriram Ravindran, University of Illinois at Chicago, USA
“Engineered mesenchymal stem cell derived exosomes for bone repair: Role of exosomal miRNA”
12.15 PM – 12.45 PM Break
Session 2
12.45 PM – 1.45 PM Himanshu Kumar, Indian Institute of Science Education and Research (IISER), India
“Can miRNA regulator of natural immunity flip the flu?”
1.45 PM – 2.30 PM Afsar Naqvi, University of Illinois at Chicago, USA
“Immunomodulatory Role of Human Herpesvirus-Encoded MicroRNA in Oral Diseases”
2.30 PM – 3.15 PM Lukas Jeker, University of Basel, Switzerland
“The miR-17-92 cluster is a central mediator of T cell activation/costimulation”
3.15 PM – 3.55 PM Mohd Wasim Nasser, University of Nebraska Medical Center, USA
“MicroRNA-1 regulates small cell lung cancer metastasis through chemokine receptor CXCR4”
3.55 PM – 4.00 PM Concluding Remarks (Afsar Naqvi & Lyndon Cooper)
